An experimental protocol is described aiming to explore the influence of Type 2 Diabetes Mellitus on the biomechanical response of the bone tissue and, also, to quantify the potential beneficial role of a pharmaceutical treatment, based on sitagliptin, a diabetes drug that increases the levels of natural substances called incretins. Twenty eight male, 10-week old Wistar rats were used, divided into three groups, i.e., the control one, the group including the diabetic rats and, finally, the group including the diabetic rats which were treated using sitagliptin. The biomechanical study was based on a series of three-point bending tests of the femora of the sacrificed rats and the analysis of the experimental data was implemented in terms of the actual geometry of the fractured cross-section. It was concluded that diabetic bones undertake larger forces despite the fact that the “diameter” of their cross-section was somehow smaller. On the contrary, the slope of the load-deflection curve (corresponding to a measure of the stiffness) of diabetic bones is slightly lower compared to the control bones. Finally, it seems that treating diabetic animals with sitagliptin only partly reverses the effect of Type 2 Diabetes Mellitus on their bone tissue, at least concerning its strength and stiffness.
How to Cite
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are allowed to retain both the copyright and the publishing rights of their articles without restrictions.
Open Access Statement
Frattura ed Integrità Strutturale (Fracture and Structural Integrity, F&SI) is an open-access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the DOAI definition of open access.
F&SI operates under the Creative Commons Licence Attribution 4.0 International (CC-BY 4.0). This allows to copy and redistribute the material in any medium or format, to remix, transform and build upon the material for any purpose, even commercially, but giving appropriate credit and providing a link to the license and indicating if changes were made.